Marpai, Inc. (MRAI) stock
MRAIOTCServices-Misc Health & Allied Services, NECFiscal year ends December 31
$3.18+0.05 (+1.60%)
Close on Oct 19, 2026Market cap $82.24MP/E –Yield –
Marpai EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Marpai's EPS for the twelve months ending Jun 30, 2026 was -$0.77. For fiscal 2025 it was -$0.95. The highest annual figure on record is -$0.95 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.95 | – |
| FY2024 | Dec 31, 2024 | -$1.92 | – |
| FY2023 | Dec 31, 2023 | -$4.14 | – |
| FY2022 | Dec 31, 2022 | -$5.23 | – |
| FY2021 | Dec 31, 2021 | -$6.36 | – |
| FY2020 | Dec 31, 2020 | -$6.40 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.18 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.13 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.26 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.20 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.28 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.21 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.08 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.30 | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.23 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.46 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.62 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.98 | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.10 | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.68 | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.63 | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.14 | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.34 | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.12 | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.37 | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.88 | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.52 | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.20 | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.28 | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.48 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?